Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis

IMPORTANCE: Commercial epicutaneous peanut immunotherapy (EPIT) and peanut oral immunotherapy (POIT) may offer significant quality-of-life improvements for patients with peanut allergy, but the cost-effectiveness of commercial peanut immunotherapies is uncharacterized. OBJECTIVE: To evaluate critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaker, Marcus, Greenhawt, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503512/
https://www.ncbi.nlm.nih.gov/pubmed/31050778
http://dx.doi.org/10.1001/jamanetworkopen.2019.3242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503512/
https://www.ncbi.nlm.nih.gov/pubmed/31050778
http://dx.doi.org/10.1001/jamanetworkopen.2019.3242

Ejemplares similares